Built on integrated platforms for peptides, proteins, and oligonucleotides, Viva PPO offers end-to-end peptide CRDMO services from discovery to commercial GMP manufacturing.
Powered by AI-driven design and 'Lab-in-the-Loop' druggability profiling, we accelerate peptide development with robust libraries and synthesis capabilities. Our innovative hybrid (SPPS/LPPS) and continuous process technologies enable seamless scale-up from mg to thousand kg, while our GLP-1 readiness and expertise in oral peptide delivery support the advancement of next-generation peptide therapeutics.
